LPL Financial’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-95,601
| Closed | -$2.26M | – | 5061 |
|
|
2023
Q4 | $2.26M | Sell |
95,601
-27,763
| -23% | -$494K | ﹤0.01% | 2318 |
|
|
2023
Q3 | $1.84M | Sell |
123,364
-8,206
| -6% | -$109K | ﹤0.01% | 2371 |
|
|
2023
Q2 | $1.44M | Buy |
131,570
+12,741
| +11% | +$119K | ﹤0.01% | 2541 |
|
|
2023
Q1 | $1.04M | Buy |
118,829
+2,616
| +2% | +$20.9K | ﹤0.01% | 2730 |
|
|
2022
Q4 | $729K | Buy |
116,213
+20,619
| +22% | +$78.4K | ﹤0.01% | 2908 |
|
|
2022
Q3 | $335K | Buy |
95,594
+44,567
| +87% | +$160K | ﹤0.01% | 3485 |
|
|
2022
Q2 | $151K | Buy |
51,027
+1,155
| +2% | +$2.76K | ﹤0.01% | 4025 |
|
|
2022
Q1 | $155K | Sell |
49,872
-4,991
| -9% | -$15.7K | ﹤0.01% | 3888 |
|
|
2021
Q4 | $185K | Buy |
54,863
+21,165
| +63% | +$80.4K | ﹤0.01% | 4007 |
|
|
2021
Q3 | $123K | Sell |
33,698
-15,000
| -31% | -$59.1K | ﹤0.01% | 4096 |
|
|
2021
Q2 | $212K | Buy |
48,698
+15,065
| +45% | +$66.8K | ﹤0.01% | 3868 |
|
|
2021
Q1 | $153K | Buy |
33,633
+14,350
| +74% | +$77.2K | ﹤0.01% | 3843 |
|
|
2020
Q4 | $111K | Sell |
19,283
-76
| -0.4% | -$575 | ﹤0.01% | 3664 |
|
|
2020
Q3 | $140K | Buy |
19,359
+8,734
| +82% | +$46.7K | ﹤0.01% | 3304 |
|
|
2020
Q2 | $37K | Buy |
+10,625
| New | +$30.7K | ﹤0.01% | 3373 |
|
|
2019
Q4 | – | Sell |
-15,239
| Closed | -$78K | – | 3438 |
|
|
2019
Q3 | $78K | Buy |
15,239
+324
| +2% | +$1.96K | ﹤0.01% | 3171 |
|
|
2019
Q2 | $107K | Sell |
14,915
-323
| -2% | -$3.66K | ﹤0.01% | 3147 |
|
|
2019
Q1 | $202K | Sell |
15,238
-9,290
| -38% | -$98.8K | ﹤0.01% | 2936 |
|
|
2018
Q4 | $193K | Sell |
24,528
-894
| -4% | -$8.51K | ﹤0.01% | 2817 |
|
|
2018
Q3 | $282K | Buy |
+25,422
| New | +$316K | ﹤0.01% | 2752 |
|
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$130K | – | 3296 |
|
|
2018
Q1 | $130K | Buy |
+10,000
| New | +$124K | ﹤0.01% | 3043 |
|